XML 31 R19.htm IDEA: XBRL DOCUMENT v3.25.3
SEGMENT INFORMATION
 9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
SEGMENT INFORMATION
NOTE 11 - SEGMENT INFORMATION

Our chief operating decision maker ("CODM"), who is our President and Chief Executive Officer, is responsible for reviewing segment performance and making decisions regarding resource allocation. Our CODM regularly reviews the results of our business through two reportable segments: Healthcare Solutions and Industrial Solutions, which are based on the industry verticals they serve. For Healthcare Solutions, those industry verticals include dental, medical devices, personalized health services and regenerative medicine. For Industrial Solutions, those industry verticals include aerospace, defense, transportation and general manufacturing.
The CODM evaluates each segment’s performance based on gross profit, which is also utilized in the annual budgeting and forecasting processes, as well as in quarterly reviews of budget-to-actual results and period-over-period variances. Beginning during the quarter ended December 31, 2024, all internal segment reporting and discussions with the CODM have been based on segment gross profit. Prior period segment results have been revised to conform with current period presentation.
The CODM does not review disaggregated asset information on the basis of the Company's segments; therefore, such information is not presented.
Revenue, cost of sales and gross profit for each of our reportable segments were as follows:

Three Months Ended Nine Months Ended
(in thousands)September 30, 2025September 30, 2024September 30, 2025September 30, 2024
Revenue:
Healthcare Solutions$42,787 $55,056 $129,123 $149,369 
Industrial Solutions48,462 57,884 151,504 179,728 
Total revenue91,249 112,940 280,627 329,097 
Cost of sales:
Healthcare Solutions26,367 31,734 76,297 86,630 
Industrial Solutions35,451 39,493 106,060 112,734 
Total cost of sales61,818 71,227 182,357 199,364 
Gross profit:
Healthcare Solutions16,420 23,322 52,826 62,739 
Industrial Solutions13,011 18,391 45,444 66,994 
Total gross profit29,431 41,713 98,270 129,733 
Selling, general and administrative34,716 57,974 118,624 166,772 
Research and development16,025 20,764 53,069 66,260 
Asset impairment charges— 143,733 — 143,733 
Foreign exchange gain (loss), net2,623 (1,960)2,171 (774)
Interest income784 1,550 3,454 5,800 
Interest expense(1,924)(606)(3,202)(1,944)
Gain on disposition— — 125,681 — 
Other income (loss), net475 (51)7,335 21,719 
Net (loss) income before income taxes
$(19,352)$(181,825)$62,016 $(222,231)

Depreciation and amortization included in the measurement of gross profit by segment were as follows:

Three Months Ended Nine Months Ended
(in thousands)September 30, 2025September 30, 2024September 30, 2025September 30, 2024
Depreciation and amortization:
Healthcare Solutions
$1,385 $1,289 $4,070 $4,009 
Industrial Solutions
$493 $726 $1,786 $2,257